Hoft, D. F., Lottenbach, K., Goll, J. B., Hill, H., Winokur, P. L., Patel, S. M., . . . Belshe, R. B. (2016). Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. J Infect Dis.
Stile di citazione ChicagoHoft, Daniel F., et al. "Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T Cell Responses Induced By a Heterologous H5 Booster Vaccination." J Infect Dis 2016.
Citazione MLAHoft, Daniel F., et al. "Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T Cell Responses Induced By a Heterologous H5 Booster Vaccination." J Infect Dis 2016.